MedTrace Logo

Food-effect Study of Ecopipam Pharmacokinetics

NCT06669091 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 25

Last updated 2025-01-27

No results posted yet for this study

Summary

Standard food-effect study to identify the effect of food on ecopipam pharmacokinetics after administration of a to-be-marketed ecopipam tablet in healthy volunteers.

Conditions

  • Food-effect

Interventions

DRUG

Ecopipam tablet

A single ecopipam 89.6 mg tablet (equivalent to ecopipam HCl 100 mg)

Sponsors & Collaborators

  • Emalex Biosciences Inc.

    lead INDUSTRY

Principal Investigators

  • Frederick Munschauer, MSc, MD, FAAN · Emalex Biosciences

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-11-05
Primary Completion
2024-12-22
Completion
2024-12-27
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06669091 on ClinicalTrials.gov